Skip to main content

Clinical Trials Using Deoxycytidine Kinase Inhibitor TRE-515

Review the clinical trials studying deoxycytidine kinase inhibitor tre-515 on this list and use the filters to refine the results by age and location. Some clinical trials are held at NCI-Designated Cancer Centers and may be supported by other organizations.

You can find more information about the types and phases of clinical trials and what to expect or use our Steps to Find a Clinical Trial.

Trials 1-1 of 1

Open-Label, Dose-Escalation With Expansion to Assess the Safety, Tolerability, and PK of TRE-515 in Subjects With Solid Tumors
Status: Active
Location: UCLA / Jonsson Comprehensive Cancer Center, Los Angeles, California